Levemir
Product Images NDC 50090-6391

Product Visual Gallery

This gallery contains 59 technical images submitted to the FDA as part of the official labeling for Levemir (NDC 50090-6391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levemir Chemical Structure.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 01)

Chemical structure diagram of the active ingredient in LEVEMIR. It shows a polypeptide chain with amino acid residues labeled, including disulfide bonds and a fatty acid side chain modification, characteristic of insulin detemir's molecular structure.*

FDA Label Image

Figure 4a (Aa947266 E27c 432b 8e04 C36168d24ddb 06)

An illustration showing a close-up of hands opening a vial by removing the cap. This instructional diagram demonstrates the first step of preparing the medication, presumably LEVEMIR, for use by removing the vial top.*

FDA Label Image

Figure 4b (Aa947266 E27c 432b 8e04 C36168d24ddb 07)

An instructional diagram showing one hand holding a vial upright while the other hand inserts a syringe needle into the vial's rubber stopper, illustrating proper technique for drawing medication from the vial. The image is labeled '4B' in the top-left corner.*

FDA Label Image

Figure 6 (Aa947266 E27c 432b 8e04 C36168d24ddb 08)

An instructional illustration showing hands preparing a syringe, with one hand holding the syringe and the other removing a cap or covering with a downward arrow indicating the direction. The image is part of a step-by-step guide, numbered as step 6.*

FDA Label Image

Figure 7 (Aa947266 E27c 432b 8e04 C36168d24ddb 09)

An instructional illustration showing a hand holding a pen device while inserting a needle. The image focuses on the correct way to attach the needle to the pen device, illustrating hand placement and needle insertion steps.*

FDA Label Image

Figure 8 (Aa947266 E27c 432b 8e04 C36168d24ddb 10)

Illustration showing a step in the preparation of a LEVEMIR insulin syringe. It depicts hands drawing liquid from a vial into a syringe, with an arrow indicating the direction of movement. This instructional graphic is part of medication administration guidance.*

FDA Label Image

Figure 9 (Aa947266 E27c 432b 8e04 C36168d24ddb 11)

An instructional illustration showing a hand holding an insulin vial and a syringe. The image depicts the step of drawing insulin from the vial into the syringe, indicated by a downward arrow.*

FDA Label Image

Figure 10 (Aa947266 E27c 432b 8e04 C36168d24ddb 12)

An instructional illustration showing two hands holding a vial and syringe. One hand holds the vial upside down, while the other hand holds the syringe needle inserted into the vial, with motion lines indicating movement, likely demonstrating the process of drawing medication into the syringe.*

FDA Label Image

Figure 1 (Aa947266 E27c 432b 8e04 C36168d24ddb 13)

An instructional illustration showing a hand holding a syringe angled downward, with the syringe needle being inserted into skin. The image indicates the direction of injection with a downward arrow, demonstrating the technique for administering the medication subcutaneously.*

FDA Label Image

Step 1 Fig B.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 28)

An instructional illustration labeled 'Figure B' demonstrating a hand twisting or removing a green-colored cap from a gray pen-like device, with arrows indicating the direction of the twisting motion.*

FDA Label Image

Step 2 Fig C.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 29)

Illustration showing a hand holding a green pen-like device, labeled as Figure C. The image likely depicts a step or part of using the LEVEMIR product pen injector by A-S Medication Solutions.*

FDA Label Image

Figure D (Aa947266 E27c 432b 8e04 C36168d24ddb 30)

An instructional illustration comparing the use of two insulin pen devices: NovoFine and NovoTwist. Both show a close-up of a hand holding a pen needle, demonstrating the direction to twist for attachment or removal.*

FDA Label Image

Figure E (Aa947266 E27c 432b 8e04 C36168d24ddb 31)

Illustration comparing two insulin pen injection techniques for NovoFine/NovoFine Plus and NovoTwist needles. It shows how to attach the needle with an arrow indicating the correct twisting motion for each needle type.*

FDA Label Image

Figure F (Aa947266 E27c 432b 8e04 C36168d24ddb 32)

An instructional illustration showing the use of two insulin pen needle types, NovoFine/NovoFine Plus and NovoTwist. The image depicts a hand attaching each needle to an insulin pen by pressing and twisting, with arrows indicating the direction of attachment.*

FDA Label Image

Figure G (Aa947266 E27c 432b 8e04 C36168d24ddb 33)

An instructional illustration divided into two panels showing the correct steps for attaching a needle to a pen device. The left panel labeled "NovoFine, NovoFine Plus" depicts screwing the needle onto the pen. The right panel labeled "NovoTwist" shows pushing the needle straight onto the pen. Each panel includes an arrow indicating the direction of needle attachment.*

FDA Label Image

Step 7 Fig H.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 34)

An instructional illustration showing a close-up of hands adjusting a dosing dial on a LEVEMIR insulin pen, highlighting the selection of 2 units as displayed on the dosage indicator window.*

FDA Label Image

Step 8 Fig I.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 35)

An illustration showing a hand positioning or tapping the top of a Levemir insulin pen device, presumably to prepare or prime the pen before injection.*

FDA Label Image

Step 9 Fig J.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 36)

An instructional illustration showing a hand holding a Levemir insulin pen with an arrow pointing upward, indicating a step in preparing or using the pen. A close-up inset highlights the pen's dosing dial or mechanism at the top.*

FDA Label Image

Step 10 Fig K.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 37)

An instructional illustration showing how to adjust the dosage dial on a Levemir insulin pen by A-S Medication Solutions. It depicts fingers rotating the dial to select a unit dose, with examples of 5 units and 24 units highlighted on the dosage window in close-up views.*

FDA Label Image

Step 10 Fig L (Aa947266 E27c 432b 8e04 C36168d24ddb 38)

An instructional diagram showing a partially used insulin pen with an example of approximately 200 units left, indicated by a blue shading. The pen is green and white with dosage marking on the side. The label "Example Approx. 200 units left" is displayed beside the pen.*

FDA Label Image

Step 11 Fig M (Aa947266 E27c 432b 8e04 C36168d24ddb 39)

An instructional illustration showing recommended injection sites on the human body front and back views. Highlighted areas include outer upper arms, abdomen below the waist but above the groin, the front of the thighs, and the upper buttocks or lower back region.*

FDA Label Image

Step 12 Fig N.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 40)

An instructional illustration showing a hand pressing down on the top of a LEVEMIR insulin pen, indicating the action to administer or dispense the dose. The image includes a downward arrow emphasizing the pressing motion, labeled as Figure N.*

FDA Label Image

Step 13 Fig O.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 41)

An instructional illustration showing the proper technique for injecting medication. It depicts a hand holding a syringe poised above the skin with the needle inserted at a 90-degree angle, accompanied by a close-up of the needle position relative to the skin.*

FDA Label Image

Step 13 Fig P.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 42)

Illustration demonstrating how to count slowly from 1 to 6 while holding and using a pen-like device, likely as part of instructions for LEVEMIR injection preparation or administration.*

FDA Label Image

Step 14 Fig Q.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 43)

An instructional illustration showing a syringe or pen needle pointed upward, likely indicating a step in preparing or using the device for injection, with a blue directional arrow pointing up. The image is labeled as Figure Q.*

FDA Label Image

Step 15 Fig S.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 45)

An instructional illustration showing the correct attachment of a needle to an injector or pen device. The image depicts the needle aligned with the pen tip, with an arrow indicating the direction to securely push the needle onto the device for injection preparation.*

FDA Label Image

Step 16 Fig T.jpg (Aa947266 E27c 432b 8e04 C36168d24ddb 46)

An instructional illustration showing two hands, one holding a device and the other pulling a green cap or cover off it. An arrow indicates the direction to pull the cap away from the device. It is labeled as Figure T.*

FDA Label Image

Flextouch Qr Code (Aa947266 E27c 432b 8e04 C36168d24ddb 50)

FDA Label Image

Important Message (Image 01)

LEVEMIR insulin solution injection carton from A-S Medication Solutions with a product NDC of 50090-6391. The packaging features the proprietary name LEVEMIR prominently along with dosage and usage details visible on the front panel, showing a clear white and blue color scheme.*

FDA Label Image

Important (Image 02)

The image shows the LEVEMIR injection vial label from A-S Medication Solutions. It includes the proprietary name LEVEMIR prominently, with a green and white color scheme. The label contains standard vial information but no specific dosage or volume details are visible in the image.*

FDA Label Image

Needle Components. (Image 03)

Instructional illustrations showing the components of three types of NovoFine needles: NovoFine, NovoFine Plus, and NovoTwist. Each row depicts the outer needle cap, inner needle cap, needle, and paper tab for the respective needle type.*

FDA Label Image

Figure A Flextouch Pen Components. (Image 04)

An illustration of the Levemir FlexTouch insulin pen showing labeled parts including the pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button. The pen body displays the Levemir FlexTouch branding and dosage markings.*

FDA Label Image

Step 15 Figure R (Image 05)

An instructional illustration showing how to rotate the NovoFine or NovoFine Plus needle cap counterclockwise to remove it, then how to pull the cap upwards to detach it from the NovoTwist pen needle before use.*

FDA Label Image

Figure 2: Graph Of Glucose Lowering Effect In Patients With Type 1 Diabetes (Image 06)

A pharmacodynamic chart for LEVEMIR showing glucose infusion rate (mg/kg/min) over 24 hours after insulin injection. It compares LEVEMIR at doses of 0.2 Units/kg and 0.4 Units/kg, with a table of corresponding pharmacodynamic parameters (AUC_GIR and GIR_max) displayed at the top.*

FDA Label Image

Figure 3: Graph Of Glucose Lowering Effect In Patients With Type 2 Diabetes (Image 07)

A pharmacodynamic chart for LEVEMIR showing glucose infusion rate (mg/kg/min) over time (hours) since insulin injection at doses of 0.6 U/kg and 1.2 U/kg. The graph includes a table of parameters with AUC_GIR and GIR_max values for each dose and shows infusion rate increasing then declining up to 16 hours post-injection.*

FDA Label Image

Important Message (Image 08)

The image shows a vial label for LEVEMIR, a medication by A-S Medication Solutions with the NDC 50090-6391. The vial label includes a barcode, dosage information sections, and a lot number area, all on a white background with black and blue text. The vial features a purple cap.*

FDA Label Image

Important Message (Image 09)

LEVEMIR injection 100 Units per mL (3 mL) cartridge packaging. The carton displays the brand name LEVEMIR prominently in blue and green text, with clear indication of drug strength and dosage form. Labeler is A-S Medication Solutions. The label includes dosing information and storage instructions as part of the printed text.*

FDA Label Image

Important (Image 10)

LEVEMIR (insulin detemir) 100 units/mL solution for injection in a 3 mL FlexTouch pen. The label displays the proprietary name LEVEMIR, concentration, dosage form, and the FlexTouch pen device. The labeler is A-S Medication Solutions. Product NDC is 50090-6391.*

FDA Label Image

Important (Image 11)

LEVEMIR vial label showing the brand name LEVEMIR, manufactured by A-S Medication Solutions. The label includes dosing instructions emphasizing the concentration of 100 units/mL for use with subcutaneous injection. The label also displays cautionary advice and product identifiers consistent with an injectable insulin product.*

FDA Label Image

Important Message (Image 12)

LEVEMIR vial label from A-S Medication Solutions, displaying product name and NDC 50090-6391. The label includes detailed prescription drug information with dosage and storage instructions visible, suitable for injectable use.*

FDA Label Image

Image Of Components For Levemir Flexpen And Needles. (Image 13)

An instructional illustration showing the components of the LEVEMIR FlexPen injection device, including the pen cap, rubber stopper, cartridge with cartridge scale, dose pointer selector, and push-button. Also depicted are the NovoFine and NovoFine Plus needle components, with labeled parts such as big outer needle cap, inner needle cap, needle, and protective tab.*

FDA Label Image

Fp A (Image 14)

An instructional illustration showing a close-up of a hand holding an insulin pen device labeled with a window. The hand is rotating or adjusting a part of the pen, indicated by a blue arrow, suggesting how to set or prepare the LEVEMIR insulin pen for use.*

FDA Label Image

Fp B (Image 15)

An instructional diagram illustrating a hand peeling off a protective cap or seal from the tip of a LEVEMIR insulin pen. An arrow indicates the direction of removal, emphasizing the step in preparing the pen for use.*

FDA Label Image

Fp C (Image 16)

An instructional illustration showing a hand removing a needle cap from a LEVEMIR insulin pen. The image emphasizes proper technique for preparing the pen before injection by pulling the cap straight off.*

FDA Label Image

Fp D (Image 17)

An instructional illustration showing a hand removing the protective cap from the needle of a LEVEMIR injection pen. The image includes a directional arrow indicating the removal motion of the cap.*

FDA Label Image

Fp E (Image 18)

An instructional illustration showing a close-up of a hand adjusting the dose selector on a blue pen device. The dose window displays '2 units selected,' demonstrating how to set the dose amount on the device associated with LEVEMIR insulin.*

FDA Label Image

Fp F (Image 19)

Illustration showing a hand holding a green insulin pen with a needle attached. The image depicts the action of the pen, indicated by motion lines around the needle, suggesting preparation or use of the injection device.*

FDA Label Image

Fp G (Image 20)

An instructional diagram showing a hand holding a LEVEMIR pen device. The hand grips the pen near the dose selector with an upward arrow indicating the motion to pull or remove a cap or part. A small inset illustrates a needle attached to the pen, suggesting preparation for injection.*

FDA Label Image

Fp H (Image 21)

An instructional illustration showing a close-up of a hand adjusting the dose selector on a LEVEMIR insulin pen. The image highlights changes in the dose window, demonstrating 5 units and 24 units selected on the dial. The pen is blue with visible dosage markings, indicating how to set insulin units for injection.*

FDA Label Image

Fp I (Image 22)

An instructional illustration showing a hand adjusting the dose on a LEVEMIR insulin pen. The thumb is pressing down on the dose selector, which is marked with numbers, indicating dose setting functionality.*

FDA Label Image

Fp J (Image 23)

An instructional illustration showing a close-up of a syringe needle poised just above skin, depicting the injection step for the LEVEMIR product by A-S Medication Solutions.*

FDA Label Image

Fp K (Image 24)

An instructional illustration showing a hand holding a blue LEVEMIR insulin pen, with an arrow pointing upward indicating the removal of the pen cap.*

FDA Label Image

Important Message (Image 25)

The image shows a LEVEMIR carton labeled with the proprietary name LEVEMIR, distributed by A-S Medication Solutions. The carton appears designed to contain insulin, featuring a grey color scheme with blue accents, though no specific dosage strength or form details are visible on this side.*

FDA Label Image

Important Message (Image 26)

LEVEMIR carton label from A-S Medication Solutions. The image shows a white and blue box with LEVEMIR prominently displayed. The product likely includes details such as NDC 50090-6391 and dosage instructions, typical for this insulin product packaging.*

FDA Label Image

Important Message (Image 27)

LEVEMIR packaging label from A-S Medication Solutions showing the proprietary name LEVEMIR. The label design features a green and yellow graphic element with the brand name prominently displayed. No specific strength or dosage form details are visible in the image.*

FDA Label Image

Important Message (Image 28)

LEVEMIR insulin 100 units/mL in a 3 mL cartridge for use with a reusable pen, from A-S Medication Solutions. The packaging includes a box with clear labeling of the product name, strength, and cartridge dosage form.*

FDA Label Image

Important Message (Image 29)

LEVEMIR vial packaging label shown with the product name LEVEMIR prominently displayed in brown font. The label indicates it is a 10 milliliter vial with a concentration of 100 units per milliliter of insulin detemir. The label also includes dosage instructions and storage information. The labeler name A-S Medication Solutions is printed at the bottom along with a barcode and product identification numbers.*

FDA Label Image

Important Message (Image 30)

LEVEMIR insulin injection 100 units/mL vial carton label from A-S Medication Solutions. The label displays the product name LEVEMIR prominently, with 'Insulin Detemir' indicated as the active ingredient. The concentration is 100 units per milliliter, and the vial volume is 10 mL. The label features product identification markings, usage instructions, and manufacturer information.*

FDA Label Image

Label Image (Lbl500906391)

LEVEMIR FLEXPEN insulin detemir injection label showing 100 units/mL strength in 5 x 3 mL prefilled pens. Label instructions include refrigeration at 36 to 46 degrees Fahrenheit and protection from light and freezing. The labeler is A-S Medication Solutions, Libertyville, IL. Product NDC is 50090-6391.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.